AIM
CLBT icon

Aigen Investment Management’s Cellebrite CLBT Stock Holding History

Aigen Investment Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,028
Closed -$138K – 586
2026
Q1 		$138K Buy
+10,028
New +$151K 0.04% 449
2025
Q3 		– Sell
-37,575
Closed -$601K – 832
2025
Q2 		$601K Buy
37,575
+3,130
+9% +$55.8K 0.08% 350
2025
Q1 		$669K Sell
34,445
-18,150
-35% -$382K 0.11% 278
2024
Q4 		$1.16M Buy
52,595
+7,598
+17% +$146K 0.2% 151
2024
Q3 		$758K Sell
44,997
-5,466
-11% -$81.1K 0.15% 206
2024
Q2 		$603K Buy
50,463
+24,525
+95% +$274K 0.12% 248
2024
Q1 		$287K Sell
25,938
-2,100
-7% -$21.4K 0.06% 449
2023
Q4 		$243K Buy
+28,038
New +$218K 0.04% 583

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Aigen Investment Management's CLBT Position: Q2 2026 in Review

Aigen Investment Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 10,028 shares — an estimated $138K sold.

Aigen Investment Management first reported a position in CLBT in Q4 2023 and held it in 8 quarters. The position peaked at $1.16M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Aigen Investment Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 10,028 Cellebrite shares in Q2 2026, an estimated $138K.
  • Aigen Investment Management first reported a position in Cellebrite in Q4 2023 and held it in 8 quarters.
  • Aigen Investment Management's Cellebrite position peaked at $1.16M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.